Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

8 months ago

Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday after fresh early trial data showed positive results for its new experimental weight loss pill. 

More Stories

Airlines cancel Bali flights after volcano spews ash miles into the sky

15 mins ago

UN calls for end of weapons supplies to Sudan’s warring parties

15 mins ago

Japan is ramping up efforts to revive its once dominant chip industry

1 hour ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Nigerian university awards $20,000 prize to best-graduating student

15 mins ago

Tinubu returns from Saudi Arabia

15 mins ago

Channel funds to industrialisation, not palliatives, Anglican primate tells FG

15 mins ago

MVG, Smith suffer shock Grand Slam exits as in-form Littler entertains

15 mins ago

Billam-Smith left in tears after emotional messages ahead of world title fight

15 mins ago